FMP
Tempest Therapeutics, Inc.
TPST
NASDAQ
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial in solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. The company was founded in 2011 and is headquartered in South San Francisco, California. Tempest Therapeutics Inc. was formerly a subsidiary of Inception Sciences, Inc.
3.62 USD
0.15 (4.14%)
About
ceo
Mr. Stephen R. Brady J.D., LLM
sector
Healthcare
industry
Biotechnology
website
https://www.tempesttx.com
exchange
NASDAQ
Description
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial in solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. The company was founded in 2011 and is headquartered in South San Francisco, California. Tempest Therapeutics Inc. was formerly a subsidiary of Inception Sciences, Inc.
CIK
0001544227
ISIN
US87978U1088
CUSIP
87978U108
Address
7000 Shoreline Court
Phone
415 798 8589
Country
US
Employee
17
IPO Date
Nov 12, 2012
Summary
CIK
0001544227
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
87978U108
ISIN
US87978U1088
Country
US
Price
3.62
Beta
-2.83
Volume Avg.
952.78k
Market Cap
80.43M
Shares
-
52-Week
0.17-9.77
DCF
1.2
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.9
P/B
-
Website
https://www.tempesttx.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest TPST News
It looks like there's no news available.
